Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain

Human Gene Therapy

Volumn 18, Issue 3, 2007, Pages 195-206

  Taymans, Jean Marc ^a   Vandenberghe, Luk H ^b,c   Van Den Haute, Chris ^a   Thiry, Irina ^b   Deroose, Christophe M ^d   Mortelmans, Luc ^d   Wilson, James M ^c   Debyser, Zeger ^b   Baekelandt, Veerle ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENO ASSOCIATED VIRUS 1; ADENO ASSOCIATED VIRUS 2; ADENO ASSOCIATED VIRUS 5; ADENO ASSOCIATED VIRUS 7; ADENO ASSOCIATED VIRUS 8; ADOLESCENT; ANIMAL TISSUE; ARTICLE; BRAIN SIZE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE TITRATION; DRUG MEGADOSE; FEMALE; GENETIC TRANSDUCTION; LOW DRUG DOSE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PUTAMEN; SEROTYPE; SUBSTANTIA NIGRA; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

ANIMALS; BRAIN; DEPENDOVIRUS; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HUMANS; MICE; MICE, INBRED C57BL; TRANSDUCTION, GENETIC;

ADENO-ASSOCIATED VIRUS; MUS; PRIMATES;

EID: 34247271439     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.178     Document Type: Article

References (33)

1. AURICCHIO, A., HILDINGER, M., O'CONNOR, E., GAO, G.P., and WILSON, J.M. (2001). Isolation of highly infectious and pure adeno-associated virus type 2 vectors with a single-step gravity-flow column. Hum. Gene Ther. 12, 71-76.
2. BAEKELANDT, V., DE STROOPER, B., NUTTIN, B., and DEBYSER, Z. (2000). Gene therapeutic strategies for neurodegenerative diseases. Curr. Opin. Mol. Ther. 2, 540-554.
3. BAEKELANDT, V., CLAEYS, A., EGGERMONT, K., LAUWERS, E., DE STROOPER, B., NUTTIN, B., and DEBYSER, Z. (2002). Characterization of lentiviral vector-mediated gene transfer in adult mouse brain. Hum. Gene Ther. 13, 841-853.
4. BAEKELANDT, V., EGGERMONT, K., MICHIELS, M., NUTTIN, B., and DEBYSER, Z. (2003). Optimized lentiviral vector production and purification procedure prevents immune response after transduction of mouse brain. Gene Ther. 10, 1933-1940.
5. BROEKMAN, M.L., COMER, L.A., HYMAN, B.T., and SENA-ESTEVES, M. (2006). Adeno-associated virus vectors serotyped with AAV8 capsid are more efficient than AAV-1 or -2 serotypes for widespread gene delivery to the neonatal mouse brain. Neuroscience 138, 501-510.
6. BURGER, C., GORBATYUK, O.S., VELARDO, M.J., PEDEN, C.S., WILLIAMS, P., ZOLOTUKHIN, S., RETER, P.J., MANDEL, R.J., and MUZYCZKA, N. (2004). Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10, 302-317.
7. BURGER, C., NASH, K., and MANDEL, R.J. (2005). Recombinant adeno-associated viral vectors in the nervous system. Hum. Gene Ther. 16, 781-791.
8. CEARLEY, C.N., and WOLFE, J.H. (2006). Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther. 13, 528-537.
9. DAVIDSON, B.L., STEIN, C.S., HETH, J.A., MARTINS, I., KOTIN, R.M., DERKSEN, T.A., ZABNER, J., GHODSI, A., and CHIORINI, J.A. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors: Transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. U.S.A. 97, 3428-3432.
10. DODGE, J.C., CLARKE, J., SONG, A., BU, J., YANG, W., TAKSIR, T.V., GRIFHTHS, D., ZHAO, M.A., SCHUCHMAN, E.H., CHENG, S.H., O'RIORDAN, C.R., SHIHABUDDIN, L.S., PASSIM, M.A., and STEWART, G.R. (2005). Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease. Proc. Natl. Acad. Sci. U.S.A. 102, 17822-17827.
11. DULL, T., ZUFFEREY, R., KELLY, M., MANDEL, R.J., NGUYEN, M., TRONO, D., and NALDINI, L. (1998). A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
12. FRANKLIN, K.B.J., and PAXINOS, G. (1997). The Mouse Brain in Stereotaxic Coordinates. (Academic Press, San Diego, CA).
13. GAO, G.P., ALVIRA, M.R., WANG, L., CALCEDO, R., JOHNSTON, J., and WILSON, J.M. (2002). Novel adeno-associated viruses from rhesus monkeys as vectors for human gene therapy. Proc. Natl. Acad. Sci. U.S.A. 99, 11854-11859.
14. GAO, G., VANDENBERGHE, L.H., ALVIRA, M., LU, Y., CALCEDO, R., ZHOU, X., and WILSON, J.M. (2004). Clades of adeno-associated viruses are widely disseminated in human tissues. J. Virol. 78, 6381-6388.
15. GAO, G., VANDENBERGHE, L.H., and WILSON, J.M. (2005). New recombinant serotypes of AAV vectors. Curr. Gene Ther. 5, 285-297.
16. GRIEGER, J.C., and SAMULSKI, R.J. (2005). Packaging capacity of adeno-associated virus serotypes: Impact of larger genomes on infectivity and postentry steps. J. Virol. 79, 9933-9944.
17. HILDINGER, M., AURICCHIO, A., GAO, G., WANG, L., CHIRMULE, N., and WILSON, J.M. (2001). Hybrid vectors based on adeno-associated virus serotypes 2 and 5 for muscle-directed gene transfer. J Virol. 75, 6199-6203.
18. KLEIN, R.L., DAYTON, R.D., LEIDENHEDVIER, N.J., JANSEN, K., GOLDE, T.E., and ZWEIG, R.M. (2006). Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol. Ther. 13, 517-527.
19. LO, W.D., QU, G., SFERRA, T.J., CLARK, R., CHEN, R., and JOHNSON, P.R. (1999). Adeno-associated virus-mediated gene transfer to the brain: Duration and modulation of expression. Hum. Gene Ther. 10, 201-213.
20. MANNO, C.S., PIERCE, G.F., ARRUDA, V.R., GLADER, B., RAGNI, M., RASKO, J.J., OZELO, M.C., HOOTS, K., BLATT, P., KONKLE, B., DAKE, M., KAYE, R., RAZAVI, M., ZAJKO, A., ZEHNDER, J., RUSTAGI, P.K., NAKAI, H., CHEW, A., LEONARD, D., WRIGHT, J.F., LESSARD, R.R., SOMMER, J.M., TIGGES, M., SABATINO, D., LUK, A., JIANG, H., MINGOZZI, F., COUTO, L., ERTL, H.C., HIGH, K.A., and KAY, M.A. (2006). Successful transduction of liver in hemophilia by AAV-factor IX and limitations imposed by the host immune response. Nat. Med. 12, 342-347.
21. MASTAKOV, M.Y., BAER, K., SYMES, C.W., LEICHTLEIN, C.B., KOTIN, R.M., and DURING, M.J. (2002). Immunological aspects of recombinant adeno-associated virus delivery to the mammalian brain. J. Virol. 76, 8446-8454.
22. PASSINI, M.A., WATSON, D.J., and WOLFE, J.H. (2004). Gene delivery to the mouse brain with adeno-associated virus. Methods Mol. Biol. 246, 225-236.
23. PATERNA, J.C., FELDON, J., and BUELER, H. (2004). Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J. Virol. 78, 6808-6817.
24. PEDEN, C.S., BURGER, C., MUZYCZKA, N., and MANDEL, R.J. (2004). Circulating anti-wild-type adeno-associated virus type 2 (AAV2) antibodies inhibit recombinant AAV2 (rAAV2)-mediated, but not rAAV5-mediated, gene transfer in the brain. J. Virol. 78, 6344-6359.
25. SCHMITZ, C., and HOF, P.R. (2005). Design-based stereology in neuroscience. Neuroscience 130, 813-831.
26. TAKEDA, S., TAKAHASHI, M., MIZUKAMI, H., KOBAYASHI, E., TAKEUCHI, K., HAKAMATA, Y., KANEKO, T., YAMAMOTO, H., ITO, C., OZAWA, K., ISHIBASHI, K., MATSUZAKI, T., TAKATA, K., ASANO, Y., and KUSANO, E. (2004). Successful gene transfer using adeno-associated virus vectors into the kidney: Comparison among adeno-associated virus serotype 1-5 vectors in vitro and in vivo. Nephron Exp. Nephrol. 96, e119-e126.
27. TENENBAUM, L., CHTARTO, A., LEHTONEN, E., VELU, T., BROTCHI, J., and LEVIVIER, M. (2004). Recombinant AAV-mediated gene delivery to the central nervous system. J. Gene Med. 6(Suppl. 1), S212-S222.
28. VANDENBERGHE, L.H., WILSON, J.M., and GAO, G. (2005). Identification of novel adeno-associated virus serotypes for use as vectors. In Gene Therapy in the Central Nervous System: From Bench to Bedside. Kaplitt, M.G., and During, M.J. eds. (Elsevier, San Diego, CA) p. 17.
29. VANDENBERGHE, L.H., WANG, L., SOMANATHAN, S., ZHI, Y., FIGUEREDO, J., CALCEDO, R., SANMIGUEL, J., DESAI, R.A., CHEN, C.S., JOHNSTON, J., GRANT, R.L., GAO, G., and WILSON, J.M. (2006). Heparin binding directs activation of T cells against adeno-associated virus serotype 2 capsid. Nat. Med. 12, 967-971.
30. WANG, A.Y., PENG, P.D., EHRHARDT, A., STORM, T.A., and KAY, M.A. (2004). Comparison of adenoviral and adeno-associated viral vectors for pancreatic gene delivery in vivo. Hum. Gene Ther. 15, 405-413.
31. WATSON, D.J., PASSINI, M.A., and WOLFE, J.H. (2005). Transduction of the choroid plexus and ependyma in neonatal mouse brain by vesicular stomatitis virus glycoprotein-pseudotyped lentivirus and adeno-associated virus type 5 vectors. Hum. Gene Ther. 16, 49-56.
32. WITTER, M.P., and AMARAL, D.G. (2004). In Rat Nervous System. Paxinos, G. ed. (Elsevier, San Diego, CA,) pp. 443-493.
33. XIAO, X., LI, J., and SAMULSKI, R.J. (1998). Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J. Virol. 72, 2224-2232.